期刊文献+

肝硬化患者血清血管紧张素转化酶和C反应蛋白水平与肝损害程度关系分析 被引量:2

下载PDF
导出
摘要 近年来研究显示,肝硬化的发生、发展伴随局部肾素-血管紧张素-醛固酮系统reninangiotensinaldosteronesystem,RAAS)变化,血管紧张素转化酶(angiotensincon—vettingenzyme,ACE)在其中发挥重要作用。同时研究证实肝硬化的进展伴随着炎症过程,C反应蛋白(c—reac—tionprotein,CRP)是亚临床炎症标志之一,也是脏器发生硬化性疾病的介质。本研究拟探讨肝硬化患者ACE与CRP的关系,为今后的治疗及预后研究奠定基础。
出处 《浙江医学》 CAS 2012年第22期1857-1858,1860,共3页 Zhejiang Medical Journal
  • 相关文献

参考文献7

  • 1张晶,宗春华,李定国,周仁建,杜学亮,周馨,徐芹芳,陆汉明.肝内肾素-血管紧张素-醛固酮系统与大鼠肝纤维化的关系[J].世界华人消化杂志,2002,10(4):397-400. 被引量:26
  • 2Rao M S. Inhibition of the renninangiotensin aldosterone system:fo-cus on aliskiren[J].J AssocPhysicians India,2010,(58):102-108.
  • 3Huang M L,Li X,Meng Y. Upregulation of an-giotensin-con-verting enzyme(ACE)in hepatic fibrosisby ACE inhibitors[J].Cli Exp Pharmacol Physiol,2010,(01):1-6.
  • 4邹奇飞,王少军,姜超,张峰.肝癌中Ang-2的表达及其临床意义[J].实用临床医药杂志,2006,10(2):44-46. 被引量:2
  • 5Lubel J S,Herath C B,Burrel L M. Liver disease and therenin-angiotensin system:Recent Discoveries and Clinical im-plications[J].Journal of Gastroenterology and Hepatology,2008,(09):1327-1338.
  • 6Batal er R,Schwabe R F,Choi Y H. NADPH oxidase signal-transduces angiotensin II in hepatic stel ate cel s and is critical in hepaticfibrosis[J].Journal of Clinical Investigation,2003.1383-1394.
  • 7Herath C B,Warner F J,Lubel J S. Upregulation of hepati-cangiotensin-converting enzyme 2(ACE2)and angiotensin,(1-7)levels in experimental biliary fibrosis[J].Journal of Hepatology,2007,(03):387-395.

二级参考文献14

  • 1WeiHong-shan LuHan-ming LiDing-guo ZhanYu-tao WangZhi-rong HuangXin.The Regulatory Role of AT 1 Receptor on Activated HSCs in Hepatic Fibrogensis: Effects of RAS Inhibitors on Hepatic Fibrosis Induced by CCI4[J].胃肠病学,2000,5(B08):125-125. 被引量:1
  • 2Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease [J]. Nat Med, 1995, 1(1): 27.
  • 3Rhee J, Hoff P M. Angiogenesis inhihitors in the treatment of cancer [J ]. Expert Opin Pharmaeother, 2005, 6 ( 10 ) :1701.
  • 4Caine G J, Harris A L, Christodoulos K, et al. Analysis of combination anti-angiogenesis therapy on markers of coagula-tion, platelet activation and angiogenesis in patients with advanced cancer [J]. Cancer Lett, 2005, 219(2): 163.
  • 5Holash J, Maisonpierre P C, Compton D, et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF [J]. Science, 1999, 284(5422): 1994.
  • 6Mitsuhashi N, Shimizu H, Ohtsuka M, et al. Angiopoietins and Tie \ 12 expression in angiogenesis and proliferation of human hepatocellular carcinoma [J ]. Hepatology, 2003, 37(5): 1105.
  • 7Hudis C A. Clinical implications of antiangiogenie therapies[J]. Oncology (Williston Park), 2005, 19(4 Suppl 3) : 26.
  • 8Grothey A, Antiangiogenic therapy in cancer: a new era has begun [J]. Oneology (Williston Park), 2005, 19(4 Suppl3): 5.
  • 9Lenz H J. Antiangiogenic agents in cancer therapy [J]. Oncology (Williston Park), 2005, 19(4 Suppl 3) : 17.
  • 10Jain R K. Antiangiogenic therapy for cancer: Current and emerging concepts [J]. Oneology (Williston Park), 2005, 19(4 Suppl 3) : 7.

共引文献25

同被引文献18

  • 1张剑平,魏红山,孙继云,肖凡,张毅,徐道振,成军.肝病患者血清血管紧张素转化酶活性变化的临床意义[J].世界华人消化杂志,2007,15(23):2553-2556. 被引量:4
  • 2S hahidS M , Fatima SN , Mahboob T. Angiotensin convertingenzyme (ACE) gene expression in experimentally induced livercirrhosis in rats. Pak J Pharm Sci,2013,26: 853-857.
  • 3Lee JY , Lee JH , K m DK, et al. C-reactive protein as a prognosticfactor for mortality in pneumonia patients with liver cirrhosis.IIepatogastroenterol,2014,61: 1331-1338.
  • 4Kim SR , Kondo F , Otono Y , et a l Serum amyloid A and C -reactive protein positive nodule in alcoholic liver cirrhosis, hardto make definite diagnosis. Hepatol R es,2014,44: 584-590.
  • 5Lin K H , Wong F L , Wu M S, et al. Serum procalcitonin and Creactiveprotein levels as markers of bacterial infection inpatients with liver cirrhosis: a systematic review and metaanalysis.Diagn Microbll Infec Dis,2014,80:72-78.
  • 6Di Martino V, Coutris C, Cervoni JP, et al. Prognostic value ofC-reactive protein levels in patients with cirrhosis LiverTransplant,2015, 21: 753-760.
  • 7Alempijevit: T ,Sokic-Milutinovic A,ToncevL,etal. Primarybiliary cirrhosis and hepatic sarcoidosis: a case reportVoinosantt Pregl,2 0 1 4,7 1 :83-86.
  • 8Grace JA, Klein S, Herath CB, et al. Activation of the MASreceptor by angiotensin-( 1-7) in the renin-angiotensin systemmediates mesenteric vasodilatation in cirrhosis. Gastroenterology,2013, 1 4 5:874-884.
  • 9FontanaM,BarisonA,BottoN, et al CMR-verified interstitialmyocardial fibrosis as a marker of subclinical cardiac involvementin LMNA mutation carriers. JACC-CardiovascImag,2 0 1 3,6:124-126.
  • 10ZhangW,XuYZ,LiuB, et al Pioglitazone upregulates angiotensinconverting enzyme 2 expression in insulin-sensitive tissues in ratswith high-fat diet-induced nonalcoholic steatohepatitis SciWorld J,2014, 2 0 1 4:603409.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部